Glucose Consumption and Rate Constants for <SUP>18</SUP>F-fluorodeoxyglucose in Human Gliomas

  • ISHIKAWA Masatsune
    Departments of Neurosurgery, Faculty of Medicine, Kyoto University
  • KIKUCHI Haruhiko
    Departments of Neurosurgery, Faculty of Medicine, Kyoto University
  • NAGATA Izumi
    Departments of Neurosurgery, Faculty of Medicine, Kyoto University
  • YAMAGATA Sen
    Departments of Neurosurgery, Faculty of Medicine, Kyoto University
  • TAKI Waro
    Departments of Neurosurgery, Faculty of Medicine, Kyoto University
  • YONEKURA Yoshiharu
    Departments of Nuclear Medicine, Faculty of Medicine, Kyoto University
  • NISHIZAWA Sadahiko
    Departments of Nuclear Medicine, Faculty of Medicine, Kyoto University
  • IWASAKI Yasushi
    Departments of Nuclear Medicine, Faculty of Medicine, Kyoto University
  • MUKAI Takao
    Departments of Nuclear Medicine, Faculty of Medicine, Kyoto University

この論文をさがす

抄録

To investigate the value of direct measurement of the rate constants by performing 18F-labeled fluorodeoxyglucose (FDG) studies of glucose consumption in human gliomas in vivo, a kinetic method with 3- and 4-parameter rate constant models for FDG uptake was used to analyze data from dynamic scans obtained by positron emission tomography after injection of FDG into 14 patients with glioma. The results were compared with those obtained by the autoradiographic method using 3- and 4-parameter rate constant models. There were no significant differences in the glucose consumption calculated by the four different methods both in the gliomas and in the contralateral intact cortex. It was found that the rate constant k4* could be neglected in calculation of glucose consumption in gliomas as well as in the contralateral intact cortex. The rate constant k3*, an index of hexokinase function, was higher in malignant gliomas than in benign gliomas and was close to that in the contralateral cortex. This study indicates that the 3-parameter autoradiographic method, which is the most common one used in clinical practice, is reliable for the calculation of glucose consumption in human gliomas. Furthermore, direct measurement of the regional rate constants for FDG by the kinetic method was found to be useful for evaluation of the biochemical and physiological characteristics of human gliomas in vivo.

収録刊行物

被引用文献 (1)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ